MétaCan
Menu
← Back to cohort
Record W1483638371

Detection of JAK2 V617F mutation in patients with myeloproliferative disorders using real-time PCR

2006· article· en· W1483638371 on OpenAlexaff
Chantal Courtemanche, Richard LeBlanc, Lise Gosselin, Marie-Guylaine Gagnon, Luc Bélanger

Bibliographic record

VenueClinical Cancer Research · 2006
Typearticle
Languageen
FieldMedicine
TopicMyeloproliferative Neoplasms: Diagnosis and Treatment
Canadian institutionsHôtel-Dieu de Québec
Fundersnot available
KeywordsBiologyEssential thrombocythemiaPoint mutationABLPolycythemia veraMutationChronic myelogenous leukemiaAlleleLeukemiaCancer researchMolecular biologyGeneticsImmunologyGeneTyrosine kinase
DOInot available

Abstract

fetched live from OpenAlex

A41 Our molecular diagnostic laboratory is using real-time PCR and conventional PCR to identify 25 translocations and mutations associated with sarcomas, leukemias, and lymphomas. Recently, a somatic point mutation in the Janus kinase 2 (JAK2) gene has been identified in patients with BCR/ABL-negative myeloproliferative disorders (MPD) in most cases of polycythemia vera and in a subset of patients with essential thrombocythemia. To detect the JAK2 V617F mutation in MPD patients, we have developed a fast real-time PCR assay that does not require subsequent sequencing. DNA is purified from whole blood and/or bone marrow, PCR is performed on a LightCycler instrument using hybridization probes, and genotype is identified from the melting curve analysis. In addition to being highly specific, melting curve analysis using hybridization probes allows to semi-quantify JAK2 V617F and wild-type alleles. In our cohort of MPD patients, we have identified 26% homozygous and 40% heterozygous for the JAK2 V167F mutation. The proportion of mutant allele varies from 10% to 70% in heterozygous. Although JAK2 V617F mutation has been associated mostly with BCR/ABL-negative MPD, we have identified a patient carrying both the JAK2 V617F mutation (60% of mutant allele) and the BCR-ABL b3;2a translocation associated with chronic myelogenous leukemia (ratio BCR/ABL over G6PDH of 9%). BCR/ABL-negative MPD patients can undergo complete remission after bone marrow transplantation; future work will then study if reappearance of JAK2 V617F mutation in some patients correlate with disease relapse and how JAK2 V617F allele proportion correlate with disease progression. In conclusion, we demonstrated that the JAK2 V617F mutation can be detected by a fast, specific, and semi-quantitative assay based on real-time PCR. This assay simplifies the diagnostic of MDP, especially of polycythemia vera, and could potentially be used to monitor response to therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.438
Teacher spread0.368 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueClinical Cancer Research→Same topicMyeloproliferative Neoplasms: Diagnosis and Treatment→French-language works237,207→